about
From Autism to Eating Disorders and More: The Role of Oxytocin in Neuropsychiatric DisordersSatiety factor oleoylethanolamide recruits the brain histaminergic system to inhibit food intakeRole of bed nucleus of the stria terminalis corticotrophin-releasing factor receptors in frustration stress-induced binge-like palatable food consumption in female rats with a history of food restriction.Evaluation of the emotional phenotype and serotonergic neurotransmission of fatty acid amide hydrolase-deficient miceCannabinoid Receptor 2 Signaling in Neurodegenerative Disorders: From Pathogenesis to a Promising Therapeutic Target.The endocannabinoid system as a target for novel anxiolytic and antidepressant drugs.Depressive-like behavior is paired to monoaminergic alteration in a murine model of Alzheimer's disease.Regulation of hypothalamic neuropeptides gene expression in diet induced obesity resistant rats: possible targets for obesity prediction?Oleoylethanolamide: a novel potential pharmacological alternative to cannabinoid antagonists for the control of appetiteThe role of endocannabinoid signaling in the molecular mechanisms of neurodegeneration in Alzheimer's disease.Endocannabinoid signaling and food addiction.Central mechanisms mediating the hypophagic effects of oleoylethanolamide and N-acylphosphatidylethanolamines: different lipid signals?The Role of Brain Cholesterol and its Oxidized Products in Alzheimer's Disease.Estrogenic suppression of binge-like eating elicited by cyclic food restriction and frustrative-nonreward stress in female rats.Eating disorders: from bench to bedside and back.5-S-cysteinyldopamine neurotoxicity: Influence on the expression of α-synuclein and ERp57 in cellular and animal models of Parkinson's disease.Linking lipid peroxidation and neuropsychiatric disorders: focus on 4-hydroxy-2-nonenal.Epigenetic regulation of nociceptin/orphanin FQ and corticotropin-releasing factor system genes in frustration stress-induced binge-like palatable food consumption.Alterations of Clock Gene RNA Expression in Brain Regions of a Triple Transgenic Model of Alzheimer's Disease.Altered expression of the CB1 cannabinoid receptor in the triple transgenic mouse model of Alzheimer's disease.Fats for thoughts: An update on brain fatty acid metabolism.Role of the area postrema in the hypophagic effects of oleoylethanolamide.Increased intake of energy-dense diet and negative energy balance in a mouse model of chronic psychosocial defeat.Inhibition of anandamide hydrolysis enhances noradrenergic and GABAergic transmission in the prefrontal cortex and basolateral amygdala of rats subjected to acute swim stress.Role of the basolateral amygdala in mediating the effects of the fatty acid amide hydrolase inhibitor URB597 on HPA axis response to stress.High dietary fat intake influences the activation of specific hindbrain and hypothalamic nuclei by the satiety factor oleoylethanolamide.Palmitoylethanolamide Dampens Reactive Astrogliosis and Improves Neuronal Trophic Support in a Triple Transgenic Model of Alzheimer's Disease: In Vitro and In Vivo Evidence.Hindbrain noradrenergic input to the hypothalamic PVN mediates the activation of oxytocinergic neurons induced by the satiety factor oleoylethanolamideVagal afferents are not necessary for the satiety effect of the gut lipid messenger oleoylethanolamideModulation of the Oxidative Stress and Lipid Peroxidation by Endocannabinoids and Their Lipid AnaloguesPharmacological Treatment of Depression in Alzheimer's Disease: A Challenging TaskChronic psychosocial defeat differently affects lipid metabolism in liver and white adipose tissue and induces hepatic oxidative stress in mice fed a high-fat dietEarly intrathecal infusion of everolimus restores cognitive function and mood in a murine model of Alzheimer's diseaseRegulation of adenosine A2A receptor gene expression in a model of binge eating in the amygdaloid complex of female rats
P50
Q26770469-8ACC189E-E5AC-4450-BEBB-5D791E932D78Q34025489-9E41D703-A41E-4AB8-A3D4-2EC964AC256FQ34067338-E482F8C0-B7E1-454A-AF3D-94E6740DAEC9Q34608846-2D6EE790-F6F3-4993-A60A-4BD78158CC79Q34680801-D88100EC-5B60-40CA-AEA3-A14400DE5B1BQ34992627-DEF5A0A9-1A87-4382-AA9D-FA167816A15CQ35179010-80F12790-FDDC-4439-8161-38E24D5D150DQ35692022-78A0939D-9CCC-4276-8D96-28470F4C36F9Q37717854-B7521398-E0A1-4BD4-B0BD-82A0B6B3EB42Q38242149-AB115552-B8A8-413C-BD85-94FF8449DE2AQ38244860-7D11C198-C2E5-428F-81C6-6AA9B4568157Q38545827-53BA8293-B3BF-4CA2-85D8-BF505A65F44FQ38590486-40751865-7F01-4282-AF25-DDF686414673Q38946106-8A52C702-AC9F-49B2-B59D-EF9BCA6A27A5Q38959757-AD435CDA-93D1-493A-A963-389A25D50485Q39055876-F059EE57-6290-4BED-8D6D-BBF797CBEB7DQ39073552-48B6E435-20FB-43F7-803F-C673FAD94DADQ40521405-D628BE68-CB05-4FE0-9E0D-09282C94C229Q41102947-50B45D67-2B8A-4916-802C-B1F2DF9DE76BQ46126467-54FA9CE3-F941-40DA-BE64-22AAC7026863Q46435544-7E0D4E55-848A-4D69-8509-A070D5B648ECQ47828138-7265A0C1-5B5C-492F-A7CC-B8D3D1EACAD0Q47951849-7F352B4D-A6E0-4033-A581-4857A7D2D2FCQ48379311-9772C989-F094-4987-9A52-0208E79C604BQ48614489-66D85D6C-D465-43F5-BB37-D11601C57301Q48789205-57EC5699-FD67-4A85-AB89-0FCBBC5A3045Q52632555-9C9BDB71-74F1-43C0-8BAF-9ADF93ADEA81Q60225184-45A44996-7B60-4ED3-8CC1-986C969A9620Q63509908-510DD89D-E0B5-40F7-9712-4E564C3BD414Q90322108-C7390302-2FDC-424E-B201-8C2997F7A9A4Q90704684-6E5393A5-3562-4677-B6A3-3B92D9CFB5BAQ91077833-14FF4731-4AA9-43F4-8EB4-0358CC633501Q91654147-B22248B5-9AD5-44E8-A5F6-D91375E58A11Q92509303-BBCCF6D5-C75A-4F21-8F76-DDBB7896B836
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Adele Romano
@ast
Adele Romano
@en
Adele Romano
@es
Adele Romano
@nl
type
label
Adele Romano
@ast
Adele Romano
@en
Adele Romano
@es
Adele Romano
@nl
altLabel
ADELE ROMANO
@en
prefLabel
Adele Romano
@ast
Adele Romano
@en
Adele Romano
@es
Adele Romano
@nl
P106
P1153
56000580300
P21
P31
P496
0000-0003-3874-2627